Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2025
2 years of board service in total across 1 board, counting each seat separately. Longest: Dianthus Therapeutics Inc., 1 year.
Dianthus Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 19, 2026 | Dianthus Therapeutics Inc. | Option exercise | +2,778 | $18.36 | $51,004 |
| Aug 19, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −2,778 | $117.55 | $326,554 |
| Aug 10, 2026 | Dianthus Therapeutics Inc. | Option exercise | +2,777 | $18.36 | $50,986 |
| Aug 10, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −70 | $107.11 | $7,498 |
| Aug 10, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −737 | $108.17 | $79,721 |
| Aug 10, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −831 | $108.95 | $90,537 |
| Aug 10, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −272 | $109.96 | $29,909 |
| Aug 10, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −470 | $111.05 | $52,194 |
| Aug 10, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −397 | $111.77 | $44,373 |
Questions about Simon Read
What boards is Simon Read on?
Simon Read sits on the board of Dianthus Therapeutics Inc.
How long has Simon Read served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2025.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.